374 related articles for article (PubMed ID: 28864645)
1. Risk of Retinal Toxicity in Longterm Users of Hydroxychloroquine.
Kim JW; Kim YY; Lee H; Park SH; Kim SK; Choe JY
J Rheumatol; 2017 Nov; 44(11):1674-1679. PubMed ID: 28864645
[TBL] [Abstract][Full Text] [Related]
2. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
Michaelides M; Stover NB; Francis PJ; Weleber RG
Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
[TBL] [Abstract][Full Text] [Related]
3. Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.
Leung LS; Neal JW; Wakelee HA; Sequist LV; Marmor MF
Am J Ophthalmol; 2015 Oct; 160(4):799-805.e1. PubMed ID: 26189086
[TBL] [Abstract][Full Text] [Related]
4. Frequency and Clinical Characteristics of Hydroxychloroquine Retinopathy in Korean Patients with Rheumatologic Diseases.
Eo DR; Lee MG; Ham DI; Kang SW; Lee J; Cha HS; Koh E; Kim SJ
J Korean Med Sci; 2017 Mar; 32(3):522-527. PubMed ID: 28145658
[TBL] [Abstract][Full Text] [Related]
5. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
[TBL] [Abstract][Full Text] [Related]
6. Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease.
Navajas EV; Krema H; Hammoudi DS; Lipton JH; Simpson ER; Boyd S; Easterbrook M
Can J Ophthalmol; 2015 Dec; 50(6):442-50. PubMed ID: 26651304
[TBL] [Abstract][Full Text] [Related]
7. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
Marmor MF; Kellner U; Lai TY; Lyons JS; Mieler WF;
Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
[TBL] [Abstract][Full Text] [Related]
8. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
Mavrikakis I; Sfikakis PP; Mavrikakis E; Rougas K; Nikolaou A; Kostopoulos C; Mavrikakis M
Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
[TBL] [Abstract][Full Text] [Related]
9. Optical coherence tomography angiography for screening of hydroxychloroquine-induced retinal alterations.
Bulut M; Akıdan M; Gözkaya O; Erol MK; Cengiz A; Çay HF
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2075-2081. PubMed ID: 30159602
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
Ugwuegbu O; Uchida A; Singh RP; Beven L; Hu M; Kaiser S; Srivastava SK; Ehlers JP
Br J Ophthalmol; 2019 Jan; 103(1):3-7. PubMed ID: 30190364
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence Lifetimes in Patients With Hydroxychloroquine Retinopathy.
Solberg Y; Dysli C; Möller B; Wolf S; Zinkernagel MS
Invest Ophthalmol Vis Sci; 2019 May; 60(6):2165-2172. PubMed ID: 31108547
[TBL] [Abstract][Full Text] [Related]
12. Imaging of Hydroxychloroquine Toxicity with Fluorescence Lifetime Imaging Ophthalmoscopy.
Sauer L; Calvo CM; Vitale AS; Henrie N; Milliken CM; Bernstein PS
Ophthalmol Retina; 2019 Oct; 3(10):814-825. PubMed ID: 31345727
[TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of the 103-hexagon multifocal electroretinogram in detection of hydroxychloroquine retinal toxicity.
Adam MK; Covert DJ; Stepien KE; Han DP
Br J Ophthalmol; 2012 May; 96(5):723-9. PubMed ID: 22328813
[TBL] [Abstract][Full Text] [Related]
14. Early effect of hydroxychloroquine therapy: relationship between cumulative dose and retinal thickness.
Agarwal P; Wong YH; Dasgupta E; Agarwal R; Livingstone BI; Ramamurthy S; Chyn GS
Cutan Ocul Toxicol; 2015; 34(3):179-84. PubMed ID: 25068998
[TBL] [Abstract][Full Text] [Related]
15. Macular retinal ganglion cell-inner plexiform layer thickness in patients on hydroxychloroquine therapy.
Lee MG; Kim SJ; Ham DI; Kang SW; Kee C; Lee J; Cha HS; Koh EM
Invest Ophthalmol Vis Sci; 2014 Nov; 56(1):396-402. PubMed ID: 25425304
[TBL] [Abstract][Full Text] [Related]
16. Assessment of parafoveal cone density in patients taking hydroxychloroquine in the absence of clinically documented retinal toxicity.
Debellemanière G; Flores M; Tumahai P; Meillat M; Bidaut Garnier M; Delbosc B; Saleh M
Acta Ophthalmol; 2015 Nov; 93(7):e534-40. PubMed ID: 25989823
[TBL] [Abstract][Full Text] [Related]
17. Detection of Hydroxychloroquine Retinal Toxicity by Automated Perimetry in 60 Rheumatoid Arthritis Patients with Normal Fundoscopic Findings.
Motarjemizadeh Q; Aidenloo NS; Abbaszadeh M
Glob J Health Sci; 2015 Jun; 8(3):59-64. PubMed ID: 26493438
[TBL] [Abstract][Full Text] [Related]
18. Evolution of retinal changes measured by optical coherence tomography in the assessment of hydroxychloroquine ocular safety in patients with systemic lupus erythematosus.
Martín-Iglesias D; Artaraz J; Fonollosa A; Ugarte A; Arteagabeitia A; Ruiz-Irastorza G
Lupus; 2019 Apr; 28(4):555-559. PubMed ID: 30755141
[TBL] [Abstract][Full Text] [Related]
19. Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.
Garrity ST; Jung JY; Zambrowski O; Pichi F; Su D; Arya M; Waheed NK; Duker JS; Chetrit Y; Miserocchi E; Giuffrè C; Kaden TR; Querques G; Souied EH; Freund KB; Sarraf D
Br J Ophthalmol; 2019 Nov; 103(11):1600-1604. PubMed ID: 30819690
[TBL] [Abstract][Full Text] [Related]
20. RAPID ONSET HYDROXYCHLOROQUINE TOXICITY.
Jeltsch BM; Sarraf D; Madjdpour D; Hanson JVM; Pfiffner FK; Koller S; Berger W; Barthelmes D; Al-Sheikh M
Retin Cases Brief Rep; 2024 May; 18(3):351-354. PubMed ID: 36857194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
